HEART TECHNOLOGY ROTABLATOR TRIALS AT UCSD, FDA CIVIL PENALTY ACTION AGAINST INFUSAID TO BE DISCUSSED AT REP. WYDEN BRIEFING WITH AGENCY STAFFERS
This article was originally published in The Gray Sheet
Executive Summary
Rep. Ron Wyden (D-Ore.) plans to query FDA staffers about clinical studies of Heart Technology's Rotablator atherectomy device at the University of California, San Diego at an April 8 briefing with the agency.